Dipeptidyl peptidase 4 inhibitors in COVID-19: Beyond glycemic control.

World J Virol · 2022 · PMC9724202 · PMID 36483108

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Studies showed a trend towards reducing mortality in COVID-19 patients with DM, especially with continued in-hospital use of DPP-4i.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.